Diabetes mellitus, glycemic control, and risk of atrial fibrillation

Journal of General Internal Medicine

Volumn 25, Issue 8, 2010, Pages 853-858

  Dublin, Sascha ^a,b   Glazer, Nicole L ^b   Smith, Nicholas L ^b,c   Psaty, Bruce M ^a,b   Lumley, Thomas ^b   Wiggins, Kerri L ^b   Page, Richard L ^d   Heckbert, Susan R ^a,b  

^a GROUP HEALTH RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

arrhythmia; atrial fibrillation; diabetes complications; diabetes mellitus; glycemic control

Indexed keywords

HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE DURATION; FEMALE; GLYCEMIC CONTROL; HEALTH CARE SYSTEM; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW;

AGED; ATRIAL FIBRILLATION; BLOOD GLUCOSE; BODY MASS INDEX; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; DIABETES COMPLICATIONS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; RISK FACTORS; TIME FACTORS;

EID: 77954424113     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-010-1340-y     Document Type: Article

References (40)

1. AG Mainous 3rd R Baker RJ Koopman, et al. 2007 Impact of the population at risk of diabetes on projections of diabetes burden in the United States: an epidemic on the way Diabetologia 50 934 40 10.1007/s00125-006-0528-5 17119914 (Pubitemid 46559242)
2. MK Rutter H Parise EJ Benjamin, et al. 2003 Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study Circulation 107 448 54 10.1161/01.CIR.0000045671.62860.98 1:CAS:528:DC%2BD3sXks1ektw%3D%3D 12551870 (Pubitemid 36158048)
3. RJ Aviles DO Martin C Apperson-Hansen, et al. 2003 Inflammation as a risk factor for atrial fibrillation Circulation 108 3006 10 10.1161/01.CIR. 0000103131.70301.4F 14623805 (Pubitemid 37553570)
4. M Bluher M Fasshauer A Tonjes J Kratzsch MR Schon R Paschke 2005 Association of interleukin-6, C-reactive protein, interleukin-10 and adiponectin plasma concentrations with measures of obesity, insulin sensitivity and glucose metabolism Exp Clin Endocrinol Diabetes 113 534 7 10.1055/s-2005-872851 1:STN:280:DC%2BD2Mrls1Ghtw%3D%3D 16235156 (Pubitemid 41585991)
5. G Yuan L Zhou J Tang, et al. 2006 Serum CRP levels are equally elevated in newly diagnosed type 2 diabetes and impaired glucose tolerance and related to adiponectin levels and insulin sensitivity Diabetes Res Clin Pract 72 244 50 10.1016/j.diabres.2005.10.025 1:CAS:528:DC%2BD28XltVeltrs%3D 16377022 (Pubitemid 43744474)
6. DM Putz WS Goldner RS Bar WG Haynes WI Sivitz 2004 Adiponectin and C-reactive protein in obesity, type 2 diabetes, and monodrug therapy Metabolism 53 1454 61 10.1016/j.metabol.2004.06.013 1:CAS:528:DC%2BD2cXovVKrs7o%3D 15536601 (Pubitemid 39410386)
7. MK Chung DO Martin D Sprecher, et al. 2001 C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation Circulation 104 2886 91 10.1161/hc4901.101760 1:CAS:528:DC%2BD38XjvVKisw%3D%3D 11739301
8. TS Tsang ME Barnes KR Bailey, et al. 2001 Left atrial volume: important risk marker of incident atrial fibrillation in 1655 older men and women Mayo Clin Proc 76 467 75 10.4065/76.5.467 1:STN:280:DC%2BD3M3mslWluw%3D%3D 11357793
9. BM Psaty TA Manolio LH Kuller, et al. 1997 Incidence of and risk factors for atrial fibrillation in older adults Circulation 96 2455 61 1:STN:280:DyaK2svnslWlsw%3D%3D 9337224
10. EJ Benjamin PA Wolf RB D'Agostino H Silbershatz WB Kannel D Levy 1998 Impact of atrial fibrillation on the risk of death: the Framingham Heart Study Circulation 98 946 52 1:STN:280:DyaK1cvgslGgsw%3D%3D 9737513
11. AD Krahn J Manfreda RB Tate FA Mathewson TE Cuddy 1995 The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study Am J Med 98 476 84 10.1016/S0002-9343(99)80348-9 1:STN:280:DyaK2M3ltVyjsw%3D%3D 7733127
12. TA Aksnes RE Schmieder SE Kjeldsen S Ghani TA Hua S Julius 2008 Impact of new-onset diabetes mellitus on development of atrial fibrillation and heart failure in high-risk hypertension (from the VALUE Trial) Am J Cardiol 101 634 8 10.1016/j.amjcard.2007.10.025 18308012 (Pubitemid 351625088)
13. GA Nichols K Reinier SS Chugh 2009 Independent contribution of diabetes to increased prevalence and incidence of atrial fibrillation Diabetes Care 32 1851 6 10.2337/dc09-0939 1:CAS:528:DC%2BD1MXhtlehs7nO 19794003
14. EJ Benjamin D Levy SM Vaziri RB D'Agostino AJ Belanger PA Wolf 1994 Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study JAMA 271 840 4 10.1001/jama.271.11.840 1:STN:280:DyaK2c7lvVSksg%3D%3D 8114238 (Pubitemid 24076851)
15. OE Johansen E Brustad S Enger A Tveit 2008 Prevalence of abnormal glucose metabolism in atrial fibrillation: a case control study in 75-year old subjects Cardiovasc Diabetol 7 28 10.1186/1475-2840-7-28 18822173
16. MR Movahed M Hashemzadeh MM Jamal 2005 Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease Int J Cardiol 105 315 18 10.1016/j.ijcard.2005.02.050 16274775 (Pubitemid 41605083)
17. S Stewart CL Hart DJ Hole JJ McMurray 2001 Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study Heart 86 516 21 10.1136/heart.86.5.516 1:STN:280:DC%2BD3MrlsFOluw%3D%3D 11602543
18. H Watanabe N Tanabe T Watanabe, et al. 2008 Metabolic syndrome and risk of development of atrial fibrillation: the Niigata preventive medicine study Circulation 117 1255 60 10.1161/CIRCULATIONAHA.107.744466 18285562 (Pubitemid 351365676)
19. Y Iguchi K Kimura J Aoki, et al. 2008 Prevalence of atrial fibrillation in community-dwelling Japanese aged 40 years or older in Japan: analysis of 41, 436 non-employee residents in Kurashiki-city Circ J 72 909 13 10.1253/circj.72.909 18503215 (Pubitemid 351879910)
20. L Frost LJ Hune P Vestergaard 2005 Overweight and obesity as risk factors for atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study Am J Med 118 489 95 10.1016/j.amjmed.2005.01.031 15866251 (Pubitemid 40615472)
21. CJ Ostgren J Merlo L Råstam U Lindblad 2004 Atrial fibrillation and its association with type 2 diabetes and hypertension in a Swedish community Diabetes Obes Metabol 6 367 74 10.1111/j.1462-8902.2004.00358.x 1:STN:280:DC%2BD2czosVymtg%3D%3D (Pubitemid 39172859)
22. A Ruigómez S Johansson MA Wallander LA Garcia Rodriguez 2005 Predictors and prognosis of paroxysmal atrial fibrillation in general practice in the UK BMC Cardiovasc Disord 5 20 10.1186/1471-2261-5-20 16008832 (Pubitemid 41471938)
23. A Ruigómez S Johansson MA Wallander LA Garcia Rodriguez 2002 Incidence of chronic atrial fibrillation in general practice and its treatment pattern J Clin Epidemiol 55 358 63 10.1016/S0895-4356(01)00478-4 11927203 (Pubitemid 34245363)
24. L Wilhelmsen A Rosengren G Lappas 2001 Hospitalizations for atrial fibrillation in the general male population: morbidity and risk factors J Intern Med 250 382 9 10.1046/j.1365-2796.2001.00902.x 1:STN:280:DC%2BD387lsFamtg%3D%3D 11887972 (Pubitemid 32989592)
25. JH Jeong 2005 Prevalence of and risk factors for atrial fibrillation in Korean adults older than 40 years J Korean Med Sci 20 26 30 10.3346/jkms.2005. 20.1.26 15716597
26. JG Smith PG Platonov B Hedblad G Engström O Melander 2010 Atrial fibrillation in the Malmö Diet and Cancer study: a study of occurrence, risk factors and diagnostic validity Eur J Epidemiol 25 95 102 10.1007/s10654-009-9404-1 19936945
27. Z Zhou D Hu 2008 An epidemiological study on the prevalence of atrial fibrillation in the Chinese population of mainland China J Epidemiol 18 209 16 10.2188/jea.JE2008021 18776706
28. S Dublin B French NL Glazer, et al. 2006 Risk of new-onset atrial fibrillation in relation to body mass index Arch Intern Med 166 2322 8 10.1001/archinte.166.21.2322 17130384 (Pubitemid 44833356)
29. TJ Wang H Parise D Levy, et al. 2004 Obesity and the risk of new-onset atrial fibrillation JAMA 292 2471 7 10.1001/jama.292.20.2471 1:CAS:528:DC%2BD2cXhtVagurfK 15562125 (Pubitemid 39552671)
30. SR Heckbert KL Wiggins NL Glazer, et al. 2009 Antihypertensive treatment with ACE inhibitors or beta-blockers and risk of incident atrial fibrillation in a general hypertensive population Am J Hypertens 22 538 44 10.1038/ajh.2009.33 1:CAS:528:DC%2BD1MXkvVGqsrc%3D 19265792
31. BM Psaty SR Heckbert D Atkins, et al. 1994 The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women Arch Intern Med 154 1333 9 10.1001/archinte.154.12.1333 1:STN:280:DyaK2c3ntVyrsg%3D%3D 8002685 (Pubitemid 24197677)
32. BM Psaty SR Heckbert TD Koepsell, et al. 1995 The risk of myocardial infarction associated with antihypertensive drug therapies JAMA 274 620 5 10.1001/jama.274.8.620 1:CAS:528:DyaK2MXosVCmtr4%3D 7637142
33. NL Smith SR Heckbert RN Lemaitre, et al. 2004 Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis JAMA 292 1581 7 10.1001/jama.292.13.1581 1:CAS:528:DC%2BD2cXot1Chtr4%3D 15467060 (Pubitemid 39314964)
34. Saunders KW, Davis RL, Stergachis A, Group Health Cooperative. In: Strom BL, ed. Pharmacoepidemiology. 4th ed. Chichester: John Wiley & Sons; 2005:234.
35. V Fuster LE Ryden DS Cannom, et al. 2006 ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) J Am Coll Cardiol 48 854 906 10.1016/j.jacc.2006.07.009 16904574 (Pubitemid 44175743)
36. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253.
37. GY Lip GI Varughese 2005 Diabetes mellitus and atrial fibrillation: Perspectives on epidemiological and pathophysiological links Int J Cardiol 105 319 21 10.1016/j.ijcard.2005.03.003 16274776 (Pubitemid 41613592)
38. H Otake H Suzuki T Honda Y Maruyama 2009 Influences of autonomic nervous system on atrial arrhythmogenic substrates and the incidence of atrial fibrillation in diabetic heart Int Heart J 50 627 41 10.1536/ihj.50.627 19809211
39. SD West DJ Nicoll JR Stradling 2006 Prevalence of obstructive sleep apnoea in men with type 2 diabetes Thorax 61 945 50 10.1136/thx.2005.057745 1:STN:280:DC%2BD28njs1emsA%3D%3D 16928713 (Pubitemid 44787163)
40. AS Gami DO Hodge RM Herges, et al. 2007 Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation J Am Coll Cardiol 49 565 71 10.1016/j.jacc.2006.08.060 17276180 (Pubitemid 46177437)